Cargando…
Intraductal Pancreatic Cancer is Less Responsive Than Cancer in the Stroma to Neoadjuvant Chemotherapy
Neoadjuvant chemotherapy (NAC) is often the treatment of choice for borderline resectable and locally advanced invasive pancreatic ductal adenocarcinoma (PDAC); however, most cancers only partially respond to therapy. We hypothesized that the location of residual neoplastic cells in resected specime...
Autores principales: | Fujikura, Kohei, Hutchings, Danielle, Braxton, Alicia M., Zhu, Qingfeng, Laheru, Daniel A., Hruban, Ralph H., Thompson, Elizabeth D., Wood, Laura D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529702/ https://www.ncbi.nlm.nih.gov/pubmed/32457408 http://dx.doi.org/10.1038/s41379-020-0572-6 |
Ejemplares similares
-
The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
por: van Pelt, G.W., et al.
Publicado: (2019) -
RNA Sequencing Identifies Frequent Mitogen-activated Protein Kinase–associated Fusion Genes in Intraductal Tubulopapillary Neoplasms of the Pancreas
por: LEE, JAE W., et al.
Publicado: (2023) -
Vimentin and tumor–stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer
por: Tian, Wenjing, et al.
Publicado: (2022) -
Milking the stroma in triple-negative breast cancer
por: Thompson, Alastair M., et al.
Publicado: (2012) -
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
por: Amato, Eliana, et al.
Publicado: (2014)